Cyclophosphamide and Veliparib in Treating Patients With Locally Advanced or Metastatic Breast Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Stanford University
Providence Health & Services
M.D. Anderson Cancer Center
Vall d'Hebron Institute of Oncology
UNC Lineberger Comprehensive Cancer Center
Dana-Farber Cancer Institute
Memorial Sloan Kettering Cancer Center
Providence Health & Services
GC Cell Corporation
Acepodia Biotech, Inc.
UNC Lineberger Comprehensive Cancer Center
Spectrum Pharmaceuticals, Inc
Mayo Clinic
Shanghai Jiao Tong University School of Medicine
Leap Therapeutics, Inc.
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Fate Therapeutics
Roswell Park Cancer Institute
City of Hope Medical Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Fate Therapeutics
Aileron Therapeutics, Inc.
Columbia University
UMC Utrecht
Hoffmann-La Roche
Technical University of Munich
AstraZeneca
Mayo Clinic
Washington University School of Medicine
Merrimack Pharmaceuticals
Shenzhen Second People's Hospital
Northwestern University
City of Hope Medical Center
Herlev Hospital
University of Washington
Case Comprehensive Cancer Center
Dana-Farber Cancer Institute
National Cancer Institute (NCI)
Northwestern University
Eisai Inc.
European Organisation for Research and Treatment of Cancer - EORTC
Cancer Research UK
NYU Langone Health